Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090974
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2004-09-07
Brief Title:
Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I Stage II or Stage IIIA Primary Breast Cancer
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-07
First Submit QC Date:
September 7 2004
Study First Post Date:
2004-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL